HD-OPM Archive
Topics › Statins

Statins: 0.2% yearly memory complaints on statin and placebo alike in Lancet CTT analysis

Louis Nervegna · Feb 06, 2026 · ♥ 12 reactions · 25 comments · original Facebook post
Statins
AI summary & key facts

Louis links the full Lancet paper and quotes the summary: pooled data from 23 CTT randomized trials found similar reports of nearly all label-listed side effects in statin and placebo groups, so noticed symptoms are mostly not caused by the drug.

Link to the full journal paper in the Lancet:

Paper · The LancetThe Lancet articlethelancet.com

Quoted:

“The researchers gathered data from 23 large-scale randomized studies from the Cholesterol Treatment Trialists' Collaboration: 123,940 participants in 19 large-scale clinical trials comparing the effects of statin therapies against a placebo (or dummy tablet), and 30,724 participants in four trials comparing more intensive versus less intensive statin therapy.

They found similar numbers of reports for those taking the statins and those taking the placebo for almost all the conditions listed in package leaflets as possible side effects. For example, each year, the number of reports of cognitive or memory impairment was 0.2% in those taking the statins, but also 0.2% in those taking the placebo. This means that while people may notice these problems while taking statins, there is no good evidence that they are caused by the statin.

Key findings:

“All of the trials included in the analyses were large-scale (involving at least 1,000 participants) and tracked patient outcomes for a median of nearly five years. The trials were double-blind, meaning that neither the trial participants nor those managing the participants or leading the study knew who was receiving which treatment, to avoid potential biases due to knowledge of treatment allocation. The list of possible side effects was compiled from those listed for the five most commonly prescribed statins.”

“Previous work by the same researchers established that most muscle symptoms are not caused by statins; statin therapy caused muscle symptoms in only 1% of people during the first year of treatment with no excess thereafter. It has also shown that statins can cause a small increase in blood sugar levels, so people already at high risk may develop diabetes sooner.”

medicalxpress.comStatins majority side effects packagemedicalxpress.com

#statinsHD

Research cited

#liver#memory#bloodtests#muscle#liverdisease#bloodsugar#cholesterol#dementia
← newer: VO2-max longevity claims rest on weak, over-extrapolated eviolder: NEJM review: LDL targets should scale with absolute risk, no →